Skip to main content
Midas Edge

AMEREN CORP

For the period ended Dec 31, 2024. Filed Feb 18, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 18, 2025

AEE$113.68-0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Ameren Corporation

CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME

Year Ended December 31,
202420232022
Operating Revenues:
Electric$6,540$6,439$6,581
Natural gas1,0831,0611,376
Total operating revenues7,6237,5007,957
Operating Expenses:
Fuel and purchased power1,6811,8122,020
Natural gas purchased for resale320355657
Other operations and maintenance1,9691,8661,937
Depreciation and amortization1,5901,3871,289
Taxes other than income taxes547522539
Total operating expenses6,1075,9426,442
Operating Income1,5161,5581,515
Other Income, Net417348226
Interest Charges663566486
Income Before Income Taxes1,2701,3401,255
Income Taxes83183176
Net Income1,1871,1571,079
Less: Net Income Attributable to Noncontrolling Interests555
Net Income Attributable to Ameren Common Shareholders$1,182$1,152$1,074
Net Income$1,187$1,157$1,079
Other Comprehensive Income (Loss), Net of Taxes
Pension and other postretirement benefit plan activity, net of income taxes (benefit) of $—, $(2), and $(4), respectively(3)(5)(14)
Unrealized net gain on derivative hedging instruments, net of income taxes of $—, $—, and $—, respectively3——
Comprehensive Income1,1871,1521,065
Less: Comprehensive Income Attributable to Noncontrolling Interests555
Comprehensive Income Attributable to Ameren Common Shareholders$1,182$1,147$1,060
Earnings per Common Share – Basic$4.43$4.39$4.16
Earnings per Common Share – Diluted$4.42$4.38$4.14
Weighted-average Common Shares Outstanding – Basic266.8262.8258.4
Weighted-average Common Shares Outstanding – Diluted267.4263.4259.5

CONSOLIDATED BALANCE SHEET

December 31,
20242023
ASSETS
Current Assets:
Cash and cash equivalents$7$25
Accounts receivable – trade (less allowance for doubtful accounts of $30 and $30, respectively)525494
Unbilled revenue346319
Miscellaneous accounts receivable96106
Inventories762733
Current regulatory assets366365
Other current assets162139
Total current assets2,2642,181
Property, Plant, and Equipment, Net36,30433,776
Investments and Other Assets:
Nuclear decommissioning trust fund1,3421,150
Goodwill411411
Regulatory assets (includes $465 and $— at 2024 and 2023 related to VIEs, respectively)2,3971,810
Pension and other postretirement benefits757581
Other assets1,123921
Total investments and other assets6,0304,873
TOTAL ASSETS$44,598$40,830
LIABILITIES AND EQUITY
Current Liabilities:
Current maturities of long-term debt (includes $17 and $— at 2024 and 2023 related to VIEs, respectively)$317$849
Short-term debt1,143536
Accounts and wages payable1,0591,136
Interest accrued196147
Customer deposits223176
Other current liabilities475501
Total current liabilities3,4133,345
Long-term Debt, Net (includes $448 and $— at 2024 and 2023 related to VIEs, respectively)17,26215,121
Deferred Credits and Other Liabilities:
Accumulated deferred income taxes and production and investment tax credits, net4,4744,176
Regulatory liabilities5,8975,512
Asset retirement obligations822772
Other deferred credits and liabilities487426
Total deferred credits and other liabilities11,68010,886
Commitments and Contingencies (Notes 2, 9, and 14)
Shareholders’ Equity:
Common stock, $.01 par value, 400.0 shares authorized – shares outstanding of 269.9 and 266.3, respectively33
Other paid-in capital, principally premium on common stock7,5137,216
Retained earnings4,6044,136
Accumulated other comprehensive loss(6)(6)
Total shareholders’ equity12,11411,349
Noncontrolling Interests129129
Total equity12,24311,478
TOTAL LIABILITIES AND EQUITY$44,598$40,830

CONSOLIDATED STATEMENT OF CASH FLOWS

Year Ended December 31,
202420232022
Cash Flows From Operating Activities:
Net income$1,187$1,157$1,079
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization1,5241,4321,373
Amortization of nuclear fuel816865
Amortization of debt issuance costs and premium/discounts191621
Deferred income taxes and production and investment tax credits, net127229170
Allowance for equity funds used during construction(76)(54)(43)
Stock-based compensation costs282624
Other871668
Changes in assets and liabilities:
Receivables(91)144(317)
Inventories(31)(67)(77)
Accounts and wages payable4(104)136
Taxes accrued34(4)(13)
Regulatory assets and liabilities99(165)(72)
Assets, other(34)(109)(74)
Liabilities, other2211552
Pension and other postretirement benefits(216)(283)(65)
Counterparty collateral, net(1)147(64)
Net cash provided by operating activities2,7632,5642,263
Cash Flows From Investing Activities:
Capital expenditures(4,319)(3,597)(3,351)
Nuclear fuel expenditures(91)(174)(29)
Purchases of securities – nuclear decommissioning trust fund(584)(266)(229)
Sales and maturities of securities – nuclear decommissioning trust fund564240216
Other(26)(1)23
Net cash used in investing activities(4,456)(3,798)(3,370)
Cash Flows From Financing Activities:
Dividends on common stock(714)(662)(610)
Dividends paid to noncontrolling interest holders(5)(5)(5)
Short-term debt, net607(533)522
Maturities and extinguishment of long-term debt(893)(100)(505)
Issuances of long-term debt2,5352,2951,467
Issuances of common stock273346333
Employee payroll taxes related to stock-based compensation(8)(20)(16)
Debt issuance costs(31)(21)(18)
Other(15)(10)—
Net cash provided by financing activities1,7491,2901,168
Net change in cash, cash equivalents, and restricted cash565661
Cash, cash equivalents, and restricted cash at beginning of year272216155
Cash, cash equivalents, and restricted cash at end of year$328$272$216
Cash Paid (Refunded) During the Year:
Interest (net of $56, $48, and $26 capitalized, respectively)$611$546$476
Income taxes, net (includes production and investment tax credit sale proceeds of $95, $49, and $—, respectively)(92)(24)(8)

CONSOLIDATED STATEMENT OF SHAREHOLDERS’ EQUITY

December 31,
202420232022
Common Stock$3$3$3
Other Paid-in Capital:
Beginning of year7,2166,8606,502
Shares issued under the ATM program233299292
Shares issued under the DRPlus and 401(k) plan404649
Stock-based compensation activity241117
Other paid-in capital, end of year7,5137,2166,860
Retained Earnings:
Beginning of year4,1363,6463,182
Net income attributable to Ameren common shareholders1,1821,1521,074
Dividends on common stock(714)(662)(610)
Retained earnings, end of year4,6044,1363,646
Accumulated Other Comprehensive Income (Loss):
Derivative financial instruments, beginning of year———
Change in derivative financial instruments3——
Derivative financial instruments, end of year3——
Deferred retirement benefit costs, beginning of year(6)(1)13
Change in deferred retirement benefit costs(3)(5)(14)
Deferred retirement benefit costs, end of year(9)(6)(1)
Total accumulated other comprehensive loss, end of year(6)(6)(1)
Total Shareholders’ Equity$12,114$11,349$10,508
Noncontrolling Interests:
Beginning of year129129129
Net income attributable to noncontrolling interest holders555
Dividends paid to noncontrolling interest holders(5)(5)(5)
Noncontrolling interests, end of year129129129
Total Equity$12,243$11,478$10,637
Common stock shares outstanding at beginning of year266.3262.0257.7
Shares issued under the ATM program2.93.23.4
Shares issued under the DRPlus and 401(k) plan0.50.60.5
Shares issued for stock-based compensation0.20.50.4
Common stock shares outstanding at end of year269.9266.3262.0
Dividends per common share$2.68$2.52$2.36
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.